Literature DB >> 30249746

Candida albicans Ras1 Inactivation Increases Resistance to Phagosomal Killing by Human Neutrophils.

Ornella Salvatori1, Ruvini U Pathirana1, Jason G Kay1, Mira Edgerton2.   

Abstract

Host phagocytic cells are crucial players in initial defense against Candida albicans infection. C. albicans utilizes MAP kinases and Ras1 stress response signaling pathways to protect itself from killing by immune cells. In this study, we tested the importance of these pathways in C. albicans phagocytosis by neutrophils and subsequent phagosomal survival. Phagocytosis was influenced by C. albicans morphology, so hyphal length of >10 μm reduced the phagocytic index (PI) 2- to 3-fold in human neutrophils. Primary human neutrophils killed 81% of phagocytosed C. albicans, while primary mouse neutrophils killed 63% of yeasts. We found that both the C. albicans Cek1 and Hog1 pathways were required for survival of phagocytosed yeast, whereas deletion of C. albicans RAS1 resulted in an 84% increase in survival within neutrophils compared to that of the wild type (WT). The absence of Ras1 did not alter reactive oxygen species (ROS) production by C. albicans; however, phagocytosed C. albicans Δ/Δras1 cells reduced ROS release by neutrophils by 86%. Moreover, C. albicans Δ/Δras1 cells had increased resistance to hydrogen peroxide as a result of high levels of catalase activity. This phenotype was specific to Ras1, since these effects were not observed in the absence of its partner Cyr1 or with its downstream target Efg1. In addition, C. albicans Δ/Δras1 cells had a significantly increased resistance to nonoxidative killing by human neutrophil peptide 1 (HNP-1) that was reversed by restoring cellular cAMP levels. These data show that C. albicans Ras1 inactivation leads to fungal resistance to both oxidative and nonoxidative mechanisms of neutrophil phagosomal killing.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Candida albicanszzm321990; Ras1; human neutrophils; phagocytosis

Mesh:

Substances:

Year:  2018        PMID: 30249746      PMCID: PMC6246910          DOI: 10.1128/IAI.00685-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  61 in total

1.  Candida albicans escapes from mouse neutrophils.

Authors:  David Ermert; Maria J Niemiec; Marc Röhm; Andreas Glenthøj; Niels Borregaard; Constantin F Urban
Journal:  J Leukoc Biol       Date:  2013-05-06       Impact factor: 4.962

2.  Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis.

Authors:  C Csank; K Schröppel; E Leberer; D Harcus; O Mohamed; S Meloche; D Y Thomas; M Whiteway
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Nonfilamentous C. albicans mutants are avirulent.

Authors:  H J Lo; J R Köhler; B DiDomenico; D Loebenberg; A Cacciapuoti; G R Fink
Journal:  Cell       Date:  1997-09-05       Impact factor: 41.582

4.  Survival of Staphylococcus aureus inside neutrophils contributes to infection.

Authors:  H D Gresham; J H Lowrance; T E Caver; B S Wilson; A L Cheung; F P Lindberg
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

5.  Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis.

Authors:  Q Qian; M A Jutila; N Van Rooijen; J E Cutler
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

6.  Transcription profiling of cyclic AMP signaling in Candida albicans.

Authors:  Doreen Harcus; André Nantel; Anne Marcil; Tracey Rigby; Malcolm Whiteway
Journal:  Mol Biol Cell       Date:  2004-07-21       Impact factor: 4.138

7.  Differential susceptibility of mitogen-activated protein kinase pathway mutants to oxidative-mediated killing by phagocytes in the fungal pathogen Candida albicans.

Authors:  David M Arana; Rebeca Alonso-Monge; Chen Du; Richard Calderone; Jesús Pla
Journal:  Cell Microbiol       Date:  2007-05-08       Impact factor: 3.715

8.  Elevated catalase expression in a fungal pathogen is a double-edged sword of iron.

Authors:  Arnab Pradhan; Carmen Herrero-de-Dios; Rodrigo Belmonte; Susan Budge; Angela Lopez Garcia; Aljona Kolmogorova; Keunsook K Lee; Brennan D Martin; Antonio Ribeiro; Attila Bebes; Raif Yuecel; Neil A R Gow; Carol A Munro; Donna M MacCallum; Janet Quinn; Alistair J P Brown
Journal:  PLoS Pathog       Date:  2017-05-22       Impact factor: 6.823

9.  Salivary metals, age, and gender correlate with cultivable oral Candida carriage levels.

Authors:  Hannah L Norris; Justin Friedman; Ziqiang Chen; Sumant Puri; Gregory Wilding; Mira Edgerton
Journal:  J Oral Microbiol       Date:  2018-03-13       Impact factor: 5.474

10.  A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages.

Authors:  Malgorzata Kubica; Krzysztof Guzik; Joanna Koziel; Miroslaw Zarebski; Walter Richter; Barbara Gajkowska; Anna Golda; Agnieszka Maciag-Gudowska; Klaudia Brix; Les Shaw; Timothy Foster; Jan Potempa
Journal:  PLoS One       Date:  2008-01-09       Impact factor: 3.240

View more
  11 in total

Review 1.  Danger signals in oral cavity-related diseases.

Authors:  Jason G Kay; Jill M Kramer; Michelle B Visser
Journal:  J Leukoc Biol       Date:  2019-02-18       Impact factor: 4.962

2.  The Role of Glycoside Hydrolases in S. gordonii and C. albicans Interactions.

Authors:  Zhiyan Zhou; Biao Ren; Jiyao Li; Xuedong Zhou; Xin Xu; Yuan Zhou
Journal:  Appl Environ Microbiol       Date:  2022-05-04       Impact factor: 5.005

3.  Fingolimod Potentiates the Antifungal Activity of Amphotericin B.

Authors:  Lu-Qi Wei; Jing-Cong Tan; Yue Wang; Yi-Kun Mei; Jia-Yu Xue; Lei Tian; Ke-Yu Song; Lu Han; Ying-Chao Cui; Yi-Bing Peng; Jing-Quan Li; Ning-Ning Liu; Hui Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-04-23       Impact factor: 5.293

4.  Type I Interferons Ameliorate Zinc Intoxication of Candida glabrata by Macrophages and Promote Fungal Immune Evasion.

Authors:  Michael Riedelberger; Philipp Penninger; Michael Tscherner; Bernhard Hadriga; Carina Brunnhofer; Sabrina Jenull; Anton Stoiber; Christelle Bourgeois; Andriy Petryshyn; Walter Glaser; Andreas Limbeck; Michael A Lynes; Gernot Schabbauer; Guenter Weiss; Karl Kuchler
Journal:  iScience       Date:  2020-05-04

5.  Functionality of the human antibody response to Candida albicans.

Authors:  Melissa Wich; Stephanie Greim; Marta Ferreira-Gomes; Thomas Krüger; Olaf Kniemeyer; Axel A Brakhage; Ilse D Jacobsen; Bernhard Hube; Berit Jungnickel
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 6.  Antimicrobial peptides: Defending the mucosal epithelial barrier.

Authors:  Karen F Johnstone; Mark C Herzberg
Journal:  Front Oral Health       Date:  2022-08-01

7.  Bacteria Modify Candida albicans Hypha Formation, Microcolony Properties, and Survival within Macrophages.

Authors:  Ornella Salvatori; Rohitashw Kumar; Sarah Metcalfe; Margaret Vickerman; Jason G Kay; Mira Edgerton
Journal:  mSphere       Date:  2020-08-05       Impact factor: 4.389

8.  Nucleic acids enrichment of fungal pathogens to study host-pathogen interactions.

Authors:  Antonio Rodríguez; Brecht Guillemyn; Paul Coucke; Mario Vaneechoutte
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

9.  Natural Variation in Clinical Isolates of Candida albicans Modulates Neutrophil Responses.

Authors:  Madhu Shankar; Tricia L Lo; Ana Traven
Journal:  mSphere       Date:  2020-08-19       Impact factor: 4.389

10.  Survival Strategies of Pathogenic Candida Species in Human Blood Show Independent and Specific Adaptations.

Authors:  Philipp Kämmer; Sylvie McNamara; Thomas Wolf; Theresia Conrad; Stefanie Allert; Franziska Gerwien; Kerstin Hünniger; Oliver Kurzai; Reinhard Guthke; Bernhard Hube; Jörg Linde; Sascha Brunke
Journal:  mBio       Date:  2020-10-06       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.